Find clinical trials for Breast Cancer in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Nashville, TN, USA:
standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...
Phase 2
Nashville, Tennessee, United States and 8 other locations
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...
Phase 2
Nashville, Tennessee, United States and 8 other locations
This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...
Phase 2
Nashville, Tennessee, United States and 10 other locations
Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer.The names of the study drugs used in this research ...
Phase 2
Nashville, Tennessee, United States and 2 other locations
This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...
Phase 2
Nashville, Tennessee, United States and 6 other locations
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...
Phase 1
Nashville, Tennessee, United States and 3 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Nashville, Tennessee, United States and 27 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Nashville, Tennessee, United States and 9 other locations
The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant
Phase 1
Nashville, Tennessee, United States and 4 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Nashville, Tennessee, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal